Objective: To evaluate the safety and cost-effectiveness of short-stay intensive care (SSIC) treatment for low-risk coronary artery bypass patients.
T he reintroduction of off-pump coronary artery bypass grafting (CABG) has resulted in important changes in on-pump CABG as well. Improved extracorporal circulation technology for on-pump CABG and the use of low-dose opioidbased anesthetic techniques enabling early extubation have freed postoperative care from conventions that had held up for decades. Fast-track treatment after cardiac surgery is becoming very popular (1) (2) (3) (4) (5) (6) (7) (8) (9) , although evidence-based research on safety and cost-effectiveness is limited. For that reason, not all cardiac centers apply this treatment.
A number of trials that evaluated early vs. late extubation had methodologic flaws in conducting intention-to-treat analyses (10) . Furthermore, they did not focus on the safety of early intensive care (IC) discharge. To the best of our knowledge, only one trial with reasonable quality (n ϭ 100) has been performed to evaluate the cost-effectiveness of early vs. late extubation (11) . Although fast-track treatment offers the possibility of discharging CABG patients from IC within a few hours, more quantitative evidence on safety and cost-effectiveness is needed on whether to take the risk of early IC discharge.
The focus of this randomized clinical equivalence trial was to evaluate the safety and cost-effectiveness of early discharge-within 8 hrs-of postsurgical CABG patients from IC to medium care (MC).
MATERIALS AND METHODS
This single-blinded, randomized, clinical equivalence trial was designed to evaluate the safety of patients who received short-stay IC (SSIC) treatment (treatment of Ͻ8 hrs) and its cost-effectiveness compared with control group patients who stayed overnight in IC (care as usual) (Box and its Figure and Table provide details on patient management).
To investigate this, the following two hypotheses were formulated to evaluate the primary outcomes: 1) SSIC patients have a comparable number of IC readmissions in the first postoperative month compared with patients in the control group, and 2) there is no difference between either group's total hospital stay.
Another three hypotheses were formulated to assess the secondary outcomes: 1) postoperative morbidity and mortality is comparable in both groups, 2) total hospital costs in the SSIC group are lower compared with costs in the control group as a consequence of lower IC costs, and 3) quality of life, measured by means of EQ-5D, is not different in between the groups.
Randomization and Blinding. Before starting the study, a random list of permuted blocks (with a length of 10) was generated for either control (n ϭ 300) or SSIC (n ϭ 300) by a computer, and the results were entered sequentially into numbered, opaque envelopes sealed with tape. Research nurses not involved in the treatment assigned consecutive patients once written consent and baseline measurement had been obtained. The envelopes were opened by the IC nurses in IC immediately postoperatively. Patients and the surgical team were blinded for the group assignments. It was impossible to blind IC-unit physicians who were responsible for discharge and readmission. However, the decision for readmission was made on the basis of objective criteria. Furthermore, the physicians were not aware that IC readmission was one of the two primary end points of the study. Whenever possible, data entry and analysis were performed without knowledge of treatment allocation. The local ethical and research council approved the study.
Patient Recruitment and Eligibility Criteria. All CABG patients who were admitted to the University Hospital of Maastricht in the period between March 2001 and March 2003 were considered for inclusion. High-risk CABG patients were separated from the lowrisk patients by means of a risk stratification system, based on the criteria of Parsonnet et al. (12) and the Society of Thoracic Surgeons (13) (Box).
Clinical Effectiveness. The medical data, obtained from different databases, case record forms, medical records, and discharge letters from both university (n ϭ 1) and district hospitals (n ϭ 5), were registered in a standardized manner. To include adverse events (morbidity and mortality), the follow-up time was Յ30 days after surgery. The power calculation was based on the primary outcome probability of IC readmission. The data on IC readmission rate was obtained from the University Hospital of Maastricht Cardio-Thoracic Surgery Department data registration system (SUMMIT). The expected probability of readmission for both groups was 5%. With a power of 80%, an alpha of 5% (one-sided), and an accepted IC readmission difference of 5% between the SSIC and control groups, 300 patients were needed in each group. Mortality was defined as any death occurring within 30 days after sur-gery. The definitions of the Society of Thoracic Surgeons were used to describe postoperative morbidity (13) .
Costs. The cost analysis was performed from a hospital perspective with a time horizon from admission to IC until 30 days postoperative. Costs were expressed in euros (2001) and identified for all patients, including the cost of clinical and outpatient procedures and the cost of inpatient hospital days.
The resource use of clinical and outpatient procedures (e.g., electrocardiography, chest radiography, cardiologist visit) in the university hospital was measured by means of the hospital billing system. Data on outpatient procedures in district hospitals were obtained by questionnaires. The number of hours or days of inpatient hospital stay in the different departments (IC, MC, low care [LC]) in the university hospital were obtained from medical records, and data on LC inpatient stays in the district hospitals were obtained from discharge letters.
The calculation of unit costs of inpatient days was performed according to the Dutch guidelines for costing (14, 15) . Guideline prices were used for the cost categories: nutrition, laundry, accommodation, cleaning, overheads, and equipment. As these prices were not available for inpatient stay on the MC department, the mean of IC and LC prices was applied. Guideline prices were converted into euros and price-indexed (16) . Hospital-specific cost prices were calculated to estimate other cost categories (nursing, specialists and residents, material and medication) (15) . Nursing costs were calculated on the basis of actual salary and occupation figures for the different departments. As specialists and residents have various tasks, it was unachievable to calculate cost prices, so guideline prices were used (14) . The cost of material and laundry was based on average use by a CABG patient. Medication costs were based on the cost calculation of a random sample of 50 patients in each group. The unit costs for one day's inpatient hospital stay were €1,082, €502, €249, and €246, respectively, for IC, MC, and LC in the university hospital and for LC in a district hospital.
All cost calculations were based on the actual situation, except for the SSIC patients who received their first hours of MC treatment in the IC department. The valuation of these hours of MC stay was based on a shadow price. Due to logistics, it was not possible to transfer these patients immediately from the IC department to MC (Box). Therefore, because MC was provided, the unit prices of MC in the MC department were used as a shadow price for these hours of MC treatment in IC.
Quality of Life. Quality of life (QoL) was measured 1 day before and 1 month postoperatively using EQ-5D (17) . The EQ-5D includes five 3-level dimensions: morbidity, self-care, usual activities, pain, and mood. The patient's answers to the five EQ-5D items were used to express a single utility value, ranging from 0 to 1. In the absence of a set of Dutch popula-tion-based utility weights, we used the most robust valuation set (18) .
The utility values were used to calculate the delta quality-adjusted life month (⌬ QALM) for follow-up. This is calculated by subtracting the utility measured at the end of follow-up from the baseline utility score divided by two. By dividing the delta by two, the average gain or loss in utility is estimated over the course of the month, assuming that the change was linear over that time period.
Statistical Analyses. All analyses were conducted according to the intention-to-treat principle. A p value of Ͻ.05 was considered to be statistically significant. All data were analyzed with SPSS, version 10.1 (SPSS, Chicago, IL). Missing values were imputed by the mean group scores.
The differences in clinical outcome measures between the two groups were analyzed by means of Chi-square or Mann Whitney test, depending on level and type of variables.
As cost and QoL data are not normally distributed and skewed, a nonparametric bootstrap sampling method with 1,000 replications was used to assess the statistical significance of the cost or QoL differences between the SSIC and the control group (19) . The mean costs (total hospital costs) and effects (⌬ QALM) of the control group were subtracted from the mean costs and effects of the SSIC group, resulting in a incremental costeffectiveness ratio (ICER). The nonparametric bootstrap sampling method was used to estimate the probability that the estimated ICERs dominate. Figure 3 shows the cost-effectiveness plane, which simultaneously represents the difference in mean costs (on the y-axis) and differences in ⌬ QALM (on the x-axis) between the SSIC and the control groups.
Sensitivity Analyses. In six 1-way analyses, the unit costs of hospital inpatient days were varied with a minimum and maximum cost estimate. The estimates of IC stay were based on the results of a study performed by Oostenbrink et al (15) . The same proportion of the costs is used to determine the range for MC and LC costs ( Table 1 ). In an additional sensitivity analysis, the shadow price of MC stay for SSIC patients who received their first hours of MC treatment in the IC department, was replaced by the IC price.
The worst-case scenario for the SSIC group was shown in a multivariate analysis. The lowest cost estimate for IC (€36.18), the highest estimate for MC (€16.74), and the lowest for LC (€11.83) were used to calculate the costs of inpatient stay.
RESULTS

Study Population. Between February 2001 and March 2003, 1,062 patients were admitted to the University Hospital
Maastricht for CABG surgery. Of these, 380 patients (35.1%) were excluded and 181 were identified as high-risk patients. A total of 199 patients were excluded for logistic reasons and research-related factors ( Fig. 1) . A total of 702 of the patients (66.1%) were eligible for inclusion and were asked to give informed consent. Of these eligible patients, 102 patients (14.6%) refused to participate in this study ( Fig. 2) . A total of 600 patients (55.5%) gave informed consent. Three of the patients included initially were excluded from the study before treatment allocation was revealed (Fig. 2) . The preoperative and intraoperative patient characteristics are described in Table 2 . The study population consisted of a group of 
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Exclusion Criteria. Exclusion criteria were: age of Ͼ78 yrs, ejection fraction of Ͻ30%, stage 3 obesity (body mass index of Ͼ40 kg/m 2 ), hemodialysis (kidney-replacing therapy), pulmonary hypertension (systolic pressure of Ͻ40 mm Hg), recent cardiovascular accident (Ͻ1 month), recent myocardial infarction (Ͻ24 hrs), cardiogenic shock (systolic blood pressure of Ͻ 80 mm Hg, central filling pressure of Ͼ 20 mm Hg, cardiac index of Ͻ1.8 Lmin Ϫ1 m Ϫ2 ), need for inotropic therapy (Ͼ5 mgg Ϫ1 min Ϫ1 dopamine or dobutamine), ongoing infarction (a significant increase of myocardial muscle creatine kinase isoenzyme within 4 hrs before surgery), or the need for intraaortic balloon pump. Other reasons for exclusion were, for instance, inability to give informed consent, inability to speak/read/understand the Dutch language, emergency surgery. For details on reasons of refusal and exclusion criteria, see Figure 1 .
Preoperative and Perioperative Treatment. The preoperative and perioperative treatment protocol was the same for all coronary artery bypass graft patients. The day before surgery, patients underwent a general screening (e.g., physical examination, electrocardiography, chest radiography, laboratory testing). During surgery, all patients were anesthetized with total intravenous infusions of propofol and a short-acting opioid. Postoperative Treatment. Postoperative treatment for the control group and short-stay intensive care group was different according to the study design. The flow chart shows the time lines for both groups (Figure) . CABG patients with a mean age of 62 yrs; 80% of the patients were men. All measured data-demographic, previous cardiac, medical, and operative historywere comparable between the two groups.
Protocol Adjustments. The discharge criteria were adapted at two points in time. First, the following criterion: PaO 2 of Ͼ10 kPa and PaCO 2 of Ͻ6.5 kPa was adapted to PaO 2 of Ͼ10 kPa and PaCO 2 Ͻ6.0 kPa, depending on observation of the patient's clinical situation. This protocol adjustment was made on February 7, 2001. The other protocol adjustment was done as follows to the criterion: "the blood gas sampling is done." To this criterion, the following part was added: "but the results do not need to have come back." This adjustment was made November 27, 2001 .
Missing Data and Protocol Deviations. Mean imputation was used because the number of missing data were very limited (details provided in Fig. 2 ). As the analysis before and after mean imputation showed the same results, the method of imputation of the missing data had no influence on the outcomes.
The protocol deviations in both groups were minimal (SSIC group, n ϭ 17; control group, n ϭ 2) ( Fig. 2) . Data were obtained from all SSIC patients and a random sample of control patients (n ϭ 100) on actual MC and IC treatment by evaluating bed lists. This was performed by checking the registration of actual extubation time, registration of pulmonary artery occlusion pressures, and number of laboratory tests performed.
Clinical Effectiveness. The primary study outcome revealed that IC readmission was lower in both groups than the expected 5%. IC readmission was 1.34% (n ϭ 4) and 2.68% (n ϭ 8) in the control group and the SSIC group, respectively. The difference of 1.13% was not significantly different (p ϭ .241; 95% confidence interval [95% CI], Ϫ0.9% to 2.9%). In other words, if patients were treated according to the SSIC protocol, a maximum of 3 of 100 patients needed IC readmission.
The reasons for the four readmissions in the control group were infec-tion, respiratory insufficiency, reexploration for bleeding, and lack of beds in MC. In the SSIC group, readmission was necessary eight times for the following reasons: cardiologic, hemodynamic (three times), reexploration for bleeding (twice), respiratory insufficiency, and order of physician.
No statistically significant differences were found between the two groups with respect to postoperative morbidity and 30 day-mortality ( Table  3 ). The patients in the SSIC group stayed in the IC unit for significantly fewer hours compared with control group patients (p ϭ .000; 95% CI, 13.1 to 9.5) ( Table 4 ). In the SSIC group, 161 patients (55%) were transferred from IC to MC within 8 hrs. The different reasons for not transferring the 137 patients in the SSIC group were: surgical (n ϭ 18), anesthetic (n ϭ 25), respiratory (n ϭ 19), hemodynamic (n ϭ 18), patient-dependent (n ϭ 27), cardiologic (n ϭ 30), protocol (n ϭ 30), and other (n ϭ 8) (patients could be grouped in more then one category). The mean
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Medium Care Treatment Protocol. For logistical reasons, it was not possible to transfer short-stay intensive care patients who fulfilled the criteria for early discharge from intensive care to the medium care situated on another floor in the hospital. Consequently, the nurse/patient ratio of one nurse to one patient was maintained. However, the care provided by the nurse was adapted to the medium care guidelines. Thus, these patients received medium care treatment in the intensive care unit according to the following protocol: 1. One full blood sample was taken at arrival to medium care, and one arterial and one venous blood sample were taken in the morning. 2. Heart rate, blood pressure, mixed venous oxygen saturation, temperature, respiratory rate, chest tube drainage, urine production, and blood and fluid balance were measured every hour.
3. If stable for 4 hrs, checks were carried out after every 2 hrs. 4. If emergencies occurred, adherence to the protocol was abandoned, and all measures necessary for the safety of the patient were taken. 5. The pulmonary artery catheter stayed in situ for safety reasons because of the investigational conditions after a patient was transferred to the medium care, but the monitor for the registration of the cardiac index was switched off. 6. The arterial catheter was left in situ, which is common use in our medium care.
Transfer of Patients 2 Days
Postoperatively. The morning after surgery, all patients were transferred to a medium care ward connected to the general ward. The nurse/patient ratio in medium care was one nurse to two patients. Patients stayed there for another 24 hrs. The treatment protocol consisted of the following: 1. One full blood sample was taken at arrival to medium care. 2. Heart rate, blood pressure, mixed venous oxygen saturation, temperature, respiratory rate, chest tube drainage, urine production, and blood and fluid balance were measured every hour.
3. If stable for 4 hrs, checks were carried out after every 2 hrs. 4. If emergencies occurred, adherence to the protocol was abandoned, and all measures necessary for the safety of the patient were taken.
On the second postoperative day, patients were admitted to the general ward (low care), where they stayed until discharge or transfer to the district hospital. postoperative total hospital stay was comparable between the two groups (p ϭ .807; 95% CI, 1.2 to Ϫ0.4).
QoL. The 1-month utility score was equal in both groups (mean [SE], 0.71 [0.01]). However, the mean and standard error for baseline utility score were 0.71 (0.01) and 0.66 (0.01) for the control group and SSIC group, respectively. This was significantly different between the two groups (mean 95% CI, Ϫ0.05 [Ϫ0.01 to Ϫ0.09). Thus, the ⌬ QALM difference between the groups was small (0.0238) but significantly different (95% CI, 0.0012 to 0.0464). Assuming that ⌬ QALMs are equal on the other days of the month, patients in the SSIC group would be in full health for 1.4 days compared with 0 days in the control group. The ⌬ QALM was 0.0015 Ϯ 0.1388 and 0.0253 Ϯ 0.1424 for the control group and SSIC group, respectively, indicating that the control group improved less in overall QoL compared with the SSIC group.
Costs. The mean total costs were €5,441 in the control group and €4,625 in the SSIC group. The mean difference was €Ϫ816. The costs were significantly lower (95% CI, €Ϫ1,581 to €Ϫ174) in the intervention group due to lower costs for clinical procedures and for IC stay at the university hospital (Table 5 ).
However, costs of the MC stay were higher in the SSIC group, indicating that part of the cost savings from the IC stay were compensated by higher costs of the MC stay. However, overall, it turned out that SSIC would lead to substantial cost Cost-effectiveness. Figure 3 shows the bootstrap results of the ICERs (cost/⌬ QALM). The ICERs were situated in the southeast quadrant, indicating that the SSIC group is dominant over the control group. Ninety-eight percent of the bootstrapped ICERs showed that SSIC patients' QoL improved more and their costs were lower compared with control patients. Only 0.016% of the bootstrapped ICERs was situated in the southwest and 0.004% in the northeast quadrant.
Sensitivity Analyses. The results of the one-way sensitivity analyses on the minimum and maximum estimate of the unit cost of inpatient hospital days showed that these results were very robust. At least 97% of the bootstrapped ICERs lay in the same quadrant as in the base case analyses. Zero percent of the bootstrapped ICERs are situated in the northwest quadrant, where the SSIC group would be inferior (less effective and more costly). As explained previously, the hypothetical cost for first hours of MC stay were calculated for SSIC patients. The unit price for these hours of MC treatment was replaced by the IC treatment unit price. This sensitivity analysis showed that calculation of the actual costs did not influence the base case findings. Even in a worst-case scenario, when the costs of IC and LC were set at the lowest cost estimate (SSIC patients stay less time in IC and LC compared with the control group) and the MC costs were set at the highest cost estimate (SSIC patients stay longer in MC compared with the control group), the results of the primary analyses still held up (Table 1 ).
DISCUSSION
Summary of the Results. SSIC discharge for low-risk CABG patients from IC to MC after 8 hrs is safe and feasible. There is no increase in IC readmissions compared with postoperative overnight IC stay. An influence of SSIC treatment on the total hospital stay, mortality, and postoperative morbidity was not observed. Furthermore, SSIC is a costeffective approach because it lowers the total hospital costs and has a positive effect on QoL. However, it is questionable whether this QoL improvement is clinically relevant.
Clinical Effectiveness. Several trials have examined strategies to reduce the duration of mechanical ventilation in patients af- ter CABG surgery. Methodologic problems occurred in these trials: for instance, a lack of information concerning concealment, a lack of intention-to-treat analyses, and flaws in power calculations dealing with missing data and loss to follow up (3-5, 7, 8) . As stated before by Meade et al. (10) , due to low adverse event rates, a trial of thousands of patients-or at least many hundreds of patients with a combined end point-would be required to study the safety of early extubation.
Our study, with safety as its primary end point, defined as the probability of being readmitted to IC, has tried to overcome this problem. Our trial and three other studies (4, 8, 20) reporting the number of IC readmissions found no significant difference between the two study groups. Although the true IC admission rate of 1.13% was lower than the expected 5%, the results were clinically acceptable. In the power calculation of our study, it was presumed that a maximum of 8% of the patients treated in SSIC needed IC readmission. The results of this trial showed that a maximum of 3% of these patients had to be readmitted to IC. The most plausible reason in our opinion for the discrepancy between real and expected readmission rate is the fact that the power calculation was performed in 1999 and the study started 2 yrs later. In addition to this, the power calculation was based on retrospective data, whereas the trial was based on prospective data.
Successful discharge of the majority of patients in the SSIC group to MC resulted in a decrease of 11 hrs in IC stay. This is more than the weighted mean difference of Ϫ7.02 (95% CI, Ϫ7.42 to Ϫ6.61] reported in a recently published review (21) . In contrast to two previous studies (4, 5), we did not notice a decrease in the number of hospital admission days. Our design meant that we deliberately focused on IC discharge only. After IC discharge, both SSIC and control patients received routine conventional care, including one overnight stay in MC. If the MC stay had been restricted to 24 hrs instead of an overnight stay, it might have been possible to decrease MC treatment to only 24 hrs. A reduction of 1 day's hospital stay is feasible, as demonstrated by the pooled results of five studies (relative ratio, Ϫ1.06; 95% CI, Ϫ1.32 to Ϫ0.080) (10) . The ability to transfer a patient may be affected by various factors unrelated to the patient's clinical situation. These factors include the availability of beds and nursing staff and, perhaps more importantly, the reluctance of medical personnel to transfer patients in the middle of the night (22) .
Cost-effectiveness. Besides evaluating medical effects, it is also important to evaluate whether SSIC influences the QoL. To our knowledge, to date, no study has investigated the differences in overall QoL for low-risk CABG patients after fasttrack treatment. The SSIC group improved significantly more in QoL compared with the control group. However, the effect is very small, indicating that its clinical relevance is doubtful.
The conventional effect measure in cost-effectiveness analyses is the qualityadjusted life year. We chose to use QALM instead of quality-adjusted life year, as the follow-up in this study was 1 month. Besides this, it is difficult to interpret a 1-month follow-up quality-adjusted life year (maximum quality-adjusted life year in 1 month is 0.083). The area under the curve is estimated in such a calculation-in other words, the sum of the utility score for both measurement moments (at baseline and 1 month) divided by 2 and multiplied by 1 ⁄12 (23). We used a ⌬ QALM (24) because baseline differences in the utility score for the QALM calculation were not suitable. Only the increment of baseline utility score and utility score at 1 month divided by 2 was used for the ⌬ QALM calculation.
Gold et al. (23) recommended employing cost-effective analysis from a societal perspective. However, we chose to perform the study from a hospital perspective as we assumed that, given the relatively short time horizon, there would be no difference in costs outside the hospital between the two groups. Furthermore, as the recovery of both groups was comparable, other medical costs like costs of primary care were not expected to be different between the groups.
It is interesting to see that the driving force of fast-track recovery is cost containment (25) , but as stated by Velasco et al. (22) , current literature has produced inconsistent evidence that only early extubation reduces the costs of cardiac surgery, not transferring the patients to MC. Grade-1 evidence has only been produced by one randomized clinical trial (11) . Other studies (20, 26 -28) that claimed to study cost reductions or even costeffectiveness gave incomplete or no information concerning cost calculation, uncertainty of outcomes, and unit prices, which are essential for interpreting the results of an economic evaluation. Furthermore, most cost studies were not randomized clinical trials, and thus, evidence of causal relations cannot be supported.
The decrease of total hospital costs in our study of the SSIC group was due to fewer laboratory blood tests being performed in IC and by a shorter stay in the high-cost IC setting. A reduction in laboratory blood tests was also reported by others (11, 27, 29) . As in our study, the early transfer to a lower level of care resulted in cost-savings (11), as 1 hr of IC stay is twice as expensive as 1 hr of MC stay (IC, €45; MC, €21).
Limitations of the Study. The SSIC intervention was restricted to the first 24 hrs of postoperative care (8 hrs of IC treatment, IC discharge, and 16 hrs of MC treatment). The conventional overnight MC treatment was maintained for both patient groups in accordance with local protocol. From a financial point of view, a reduction of up to 24 hrs of MC treatment would have resulted in additional costsavings, but for purity of study findings, it was necessary to separate these factors.
We chose only one decision moment to transfer SSIC patients from IC to MC to minimize protocol deviations. This moment was after 8 hrs of IC treatment. It might have been more effective if the decision to transfer the SSIC patients had also been taken 10 or 12 hrs after IC admission.
It is not possible to extrapolate our findings to higher-risk CABG patients.
We used data obtained from an English population for the valuation of the EQ-5D items. One may argue that these valuations may differ from the Dutch population; however, no Dutch value set is currently available, and we used the one that was recommended as being the most robust (30) .
The general applicability of the results may be limited because not all patients who fulfilled the inclusion criteria were included. Patients who refused to participate in the study were on average older, a higher proportion of them were women, and they generally had a lower ventricle ejection fraction. Furthermore, the ability to generalize may be limited due to the fact that this study was a single-center study. Other hospitals may use other treatment protocols and have different patient/nurse ratios in IC and MC that may influence the actual cost savings.
CONCLUSIONS
This is the first randomized clinical trial that shows that a short stay in IC is safe for low-risk CABG patients. The IC readmission rate was very low in SSIC patients, and postoperative complications and mortality in SSIC patients were comparable with patients who stayed overnight in IC. SSIC is also a cost-effective approach. It lowers the total hospital costs, and it has a positive effect on QoL. SSIC can be considered as an alternative for conventional postoperative IC treatment for low-risk CABG patients. 
